What this means
Scientists tested chemicals that either blocked or boosted a protein that joins mitochondria, the parts that power cells. Boosting it made worms live longer, and blocking it made them live shorter.
Plain-English summary written by an AI model from the abstract. The original is below.
- Who it was tested in
- C. elegans roundworms grown in cultures
- Kind of research
- Research in animals or cells
The science
- Original title
- Mitofusin Activation Delays Aging in Caenorhabditis elegans.
- Authors
- Weigele J, Zhang L, Li J et al.
- Journal
- Cells
- Published
- Oct 16, 2026
- Study type
- Lab or animal study · indexed as animal research
- PMID
- 42882487 ↗
Abstract
Age-linked tissue dysfunction is associated with mitochondrial degeneration manifested as organelle fragmentation and respiratory dysfunction. Efforts to mitigate downstream consequences of mitochondrial degeneration, as with ROS scavengers, have not translated to the human condition. We posit that intrinsic fusion-mediated mechanisms for mitochondrial protection modulate aspects of aging linked to mitochondrial abnormalities. In C. elegans roundworms mitochondrial fusion is mediated by the mitofusin ortholog Fuzzy Onion-1 (fzo-1). Here, the addition of a mitofusin inhibitor, MFI8, to cultures of age-synchronized C. elegans shortened worm lifespan in a concentration-dependent manner. Reciprocally, the mitofusin activators Chimera and 8015-P2 prolonged worm survival in a dose-dependent manner. The pro-survival effect of Chimera was absent in worms lacking its protein target, FZO-1, and at lower concentrations Chimera-amplified survival was further increased by absence of the mitochondrial fission protein that acts in opposition to fzo-1, DRP-1. The mitofusin activator 8015-P2, which is more potent than Chimera, exhibited greater anti-aging effects on lifespan and improved worm healthspan measured as forced swimming activity and resistance to thermal and oxidative stresses. These proof-of-concept worm studies identify aging phenotypes reciprocally related to fzo-1/mitofusin activation status. As 8015-P2 is under development for use in human neurodegenerative diseases, it might alleviate aging phenotypes evoked by mitochondrial degeneration in higher species.
Weigele J, Zhang L, Li J et al. Mitofusin Activation Delays Aging in Caenorhabditis elegans. Cells. 2026. doi:10.3390/cells15191789. PMID: 42882487. https://pubmed.ncbi.nlm.nih.gov/42882487/